Thematic Session

Biotechnological Drugs from R&D to Production
Moderator: Prof. Dr. Ali Demir SEZER, Marmara University Faculty of Pharmacy
• Dr. Pharm. Onur PINARBAŞLI, İLKO Pharmaceuticals R&D Director
• Dr. Bilgen DÖLEK UÇAROL, AMGEN Turkey Market Access and Health Policy Leader
• Ali ÖZÜER, AbdiBio Group Chairman
• Dr. Hasan Ersin ZEYTİN, Yerlika CEO

TÜSEB Session

Current Personalized Medicine Applications with Genomic Approach

• Prof. Dr. Fatma Duygu Özel DEMİRALP, Turkey Biotechnology Institute President

Sanofi Satellite Session

Journey from Big Data to Early Diagnosis with AI Support in Rare Diseases

Moderator: Dr. Hasan Berk BARIŞCIL, SANOFI Rare Diseases Medical Director

• Dr. Özgür SEZER, T.R. Ministry of Health Health Information Systems General Director
• Assoc. Prof. Dr. Engin KÖSE, Ankara University Department of Pediatric Metabolism

Thematic Session

Clinical Research and Artificial Intelligence in Biotechnological Drugs

Moderator: Prof. Dr. Yağız ÜRESİN, Istanbul University

• Umut MÜREN, Sanofi Turkey and Middle East Countries Clinical Research Unit Director
• Birkan AVER, Pfizer Turkey Primary Healthcare Category Medical Area Manager

• Prof. Dr. Ali Demir SEZER, Marmara University Faculty of Pharmacy
• Prof. Dr. Orhan AYDIN, TUBITAK President

TUBITAK Session

R&D Ecosystem and Support in Biotechnological Drugs

• Işık AŞAR, TUBITAK TEYDEB - BIOTEG Group Coordinator

Thematic Session

API, Excipient Production and Supply Chain in Conventional Drugs

Moderator: Adil KAYA, ATABAY Pharmaceuticals Public and Academic Relations Director

• Berkay BOZKUŞ, Eczacıbaşı Healthcare Group Supply Chain Director

İBG İzmir Session

Biotechnological Drug Development Processes

Moderator: Prof. Dr. Mehmet İNAN, Izmir Biomedicine and Genome Center Director

Conventional Drug Production from Synthesis to Finished Product and Market Access

Moderator: Assoc. Prof. Dr. Devrim Demir DORA, Akdeniz University

• Dr. Ümit DERELİ, AIFD General Secretary
• Vedat EĞİLMEZ, İEİS Public and Academic Relations Coordinator
• Op. Dr. Sami TÜRKOĞLU, TİSD General Secretary

Thematic Session

General Health Insurance and Sustainability of Health Financing

Moderator: Prof. Dr. Zafer ÇALIŞKAN, Hacettepe University

• Spec. Pharm. Ayşegül GÜNBEY ÖZTEK, Social Security Institution Department Head
• Prof. Dr. Yusuf ÇELİK, Acıbadem University Faculty of Health Sciences
• Assoc. Prof. Dr. Güvenç KOÇKAYA, Econix Research

16.00 - 16.20

16.20 - 16.40

16.40 - 17.20

17.20 - 17.30

Symposium Conclusion Session

General Evaluation
Highlighted Findings
Discussion - Q&A
Group Photo Session

Rare Diseases and Global R&D Collaborations Workshop

Moderator: Prof. Dr. Uğur ÖZBEK, Izmir Biomedicine and Genome Center

Personalized Medicine: From Genome to Treatment Workshop

Moderator: Prof. Dr. Cengizhan ÖZTÜRK, Boğaziçi University HTTM

AI-Based Drug Development

Moderator: Prof. Dr. Hasan TÜRKEZ, Atatürk University

• Prof. Dr. Adil MARDİNOĞLU, KTH-Royal Institute of Technology-SciLifeLabs
• Dr. Cem BAYDAR, Afendis Capital Board Member
• Dr. Duygu DAĞLIKOCA, Trustlife Ventures R&D Center General Manager

İTÜ ARI Teknokent Panel

Entrepreneurship in the Light of Science: Transformative Power in Health Technologies

Moderator: Dr. Asım ŞENGÖR, İTÜ ARI Teknokent -Lifetech Program Coordinator

Dark Factories

Moderator: Dr. Volkan ÖZGÜZ, Boğaziçi University Technology Transfer Office General Manager

• Lukasz Iskra, Pharma MES Expert, Vimachem
• Melda DEMİRDÖVEN, Co-Founder & CEO at Innovigent Consulting Services